ADC Therapeutics SA (ADCT)

USD 1.21

(-0.82%)

Inventory Summary of ADC Therapeutics SA

ADC Therapeutics SA's latest annual inventory in 2023 was 16.17 Million USD , down -12.86% from previous year.
ADC Therapeutics SA's latest quarterly inventory in 2024 Q2 was 15.19 Million USD , down -5.04% from previous quarter.
ADC Therapeutics SA reported annual inventory of 18.56 Million USD in 2022, up 66.91% from previous year.
ADC Therapeutics SA reported annual inventory of 11.12 Million USD in 2021, up 71.13% from previous year.
ADC Therapeutics SA reported quarterly inventory of 15.19 Million USD for 2024 Q2, down -5.04% from previous quarter.
ADC Therapeutics SA reported quarterly inventory of 22.72 Million USD for 2023 Q3, up 16.99% from previous quarter.

Annual Inventory Chart of ADC Therapeutics SA (2023 - 2016)

Historical Annual Inventory of ADC Therapeutics SA (2023 - 2016)

Year	Inventory	Inventory Growth
2023	16.17 Million USD	-12.86%
2022	18.56 Million USD	66.91%
2021	11.12 Million USD	71.13%
2020	6.49 Million USD	162.9%
2019	2.47 Million USD	105.32%
2018	1.2 Million USD	310.92%
2017	293 Thousand USD	0.0%
2016	- USD	0.0%

Year	Inventory	Inventory Growth
2024 Q1	15.99 Million USD	-1.11%
2024 Q2	15.19 Million USD	-5.04%
2023 Q3	22.72 Million USD	16.99%
2023 Q1	18.25 Million USD	-1.69%
2023 FY	16.17 Million USD	-12.86%
2023 Q4	16.17 Million USD	-28.82%
2023 Q2	19.42 Million USD	6.45%
2022 Q1	11.83 Million USD	6.44%
2022 FY	18.56 Million USD	66.91%
2022 Q4	18.56 Million USD	17.9%
2022 Q3	15.74 Million USD	7.47%
2022 Q2	14.65 Million USD	23.75%
2021 Q2	7.71 Million USD	0.0%
2021 Q3	8 Million USD	3.76%
2021 Q4	11.12 Million USD	38.89%
2021 FY	11.12 Million USD	71.13%
2021 Q1	- USD	-100.0%
2020 Q2	- USD	0.0%
2020 Q3	- USD	0.0%
2020 Q1	- USD	-100.0%
2020 FY	6.49 Million USD	162.9%
2020 Q4	6.49 Million USD	0.0%
2019 Q2	1.00 USD	0.0%
2019 Q4	2.47 Million USD	0.0%
2019 FY	2.47 Million USD	105.32%
2019 Q1	- USD	-100.0%
2018 Q1	- USD	0.0%
2018 Q3	- USD	0.0%
2018 Q4	1.2 Million USD	0.0%
2018 FY	1.2 Million USD	310.92%
2017 FY	293 Thousand USD	0.0%
2016 FY	- USD	0.0%

Peer Inventory Comparison of ADC Therapeutics SA

Name	Inventory	Inventory Difference
Alto Neuroscience, Inc.	- USD	-Infinity%
Annovis Bio, Inc.	- USD	-Infinity%
Biohaven Pharmaceutical Holding Company Ltd.	- USD	-Infinity%
Ginkgo Bioworks Holdings, Inc.	46 Thousand USD	-35067.391%
Nuvation Bio Inc.	- USD	-Infinity%
Nuvation Bio Inc.	- USD	-Infinity%
Arcus Biosciences, Inc.	- USD	-Infinity%
Zymeworks Inc.	1.00 USD	-1617699900.0%